Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Placebo-controlled, Parallel, Randomized (1:1), Double-blind Study Over 6 Months to Evaluate the Efficacy and Safety of the Food Supplement Olistic Women.

NCT07111312 is registered in ClinicalTrials.gov with Olistic Research Labs S.L. as lead sponsor.

NCT NCT07111312
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07111312 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Placebo-controlled, Parallel, Randomized (1:1), Double-blind Study Over 6 Months to Evaluate the Efficacy and Safety of the Food Supplement Olistic Women.
Lead sponsor
Olistic Research Labs S.L.
Phase
Not applicable
Overall status
Completed
Start date
October 10, 2023
Completion date
September 23, 2025
Enrollment
106 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

telogen effluvium